UNSPSC 51284603: Ertapenem

This classification denotes a beta-lactam antibiotic with the molecular formula C22H25N3O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G32F6EID2H, chemically known as 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-(((3-carboxyphenyl)amino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4r-(3(3s*,5s*),4alpha,5beta,6beta(r*)))- but generally known as ertapenem, which bears US NIH Compound Identifier 150610.

UNSPSC 51284603 Ertapenem, a Commodity code, does not reflect the scope of work actually being solicited under this classification in recent state and local procurement activity. The recent opportunities posted against this code—a county health department's procurement for naloxone and drug deactivation systems, a state RFI on direct-to-manufacturer prescription programs, a city fire department's medical and first aid supplies bid, and a multi-state cooperative purchasing RFP for generic pharmaceuticals and OTC products—show no activity related to ertapenem, a carbapenem antibiotic. The code mismatch suggests either a data alignment issue or minimal current state and local procurement activity specific to ertapenem as a line item. State and local healthcare purchasing under pharmaceutical codes typically involves broader medical product categories, cooperative purchasing through multi-state alliances, and delivery through authorized wholesaler networks, but ertapenem itself does not appear in the representative recent solicitations.

Geographic activity spans Florida, Texas, Minnesota, and Oregon across recent postings, with involvement from county health departments, state HHS commissions, city fire departments, and multi-state cooperative purchasing consortia. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP (S1070000015802, due March 26, 2026) represents the most comprehensive recent opportunity, seeking manufacturers of generic pharmaceuticals with NDC-specific pricing, cGMP and DSCSA compliance, and relationships with authorized wholesalers including AmerisourceBergen and Cardinal Health, with a contract term of two years beginning July 1, 2026. The City of Tampa's medical supplies bid (26P00145, due March 13, 2026) was sheltered for certified Small Local Business Enterprises with an estimated contract value of $700,000.00. Given the code's nominal scope does not align with actual recent procurement, this code warrants careful verification before pursuing opportunities.